 |
| Regulatory Affairs- US FDA Interaction |
|
Regulatory Affairs and FDA /International Regulatory Agency Interaction is one of our key functions.
We take a strategic approach to the therapeutic product and integrate regulatory, patient recruitment, reimbursement, and marketing concerns into the clinical plan up front.
We believe in an upfront and free communication with the FDA and international regulatory bodies to make sure that we address all the regulatory concerns in the clinical and regulatory plan. We involve your key opinion leaders to create therapeutic justifications when presenting the novel therapies to the regulatory authorities. If the regulatory authorities are on the same page as you are, your regulatory approval process becomes much more simplified.
After a thorough review, we will develop a strategic regulatory plan tailored to your specific product. This plan will take your business objectives and factors about markets, countries, and regulatory agencies into account.
It is the strategy that defines an efficient and effective pathway to market approval and guides the regulatory tactics.
TrialMed consultants have extensive experience with the U.S. FDA and international regulatory bodies.
Therefore, you can count on NDA, 510(k), PMA and BLA submissions that move smoothly through the approval process.
|
|
|
|
|
